Vidofludimus is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor.

Vidofludimus is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor.

Vidofludimus is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor.

Lanifibranor is a pan peroxisome proliferator-activated receptor (PPAR) agonist.

Methotrexate Sodium is the sodium salt of methotrexate, an antimetabolite with antineoplastic and immunomodulating properties.

Methazolamide is a sulfonamide derivate and carbonic anhydrase inhibitor with potential antineoplastic activity.

Orlistat is an inhibitor of pancreatic and gastric lipase and a commonly used weight loss agent

Mevastatin is an HMG-CoA reductase inhibitor that was initially isolated from the mold Pythium ultimum.